Endocrinology Flashcards

1
Q

Type 1a vs. Type 1b diabetes

A

Type 1a - immune mediated (95%)
Type 1b - idiopathic (<5%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Autoantibodies in T1DM

A
  • Glutamic acid decarboxylase (GAD65)
  • Insulin (IAA)
  • Tyrosine phosphatases (IA-2, IA-2B)
  • ZnT8

Not routinely used in diagnosis
Presence of autoantibodies predicts risk of developing clinical diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Diagnosis of T1DM

A

Random BSL >11.1 with keoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical clues towards T1DM in diagnosis

A

○ Rate of development of hyperglycaemia symptoms
○ Presence of ketosis
○ Personal/family history of AI disorders
○ Absence of family history of T2DM
○ Absence of other features of metabolic syndrome
○ Failure to respond to non-insulin treatments
Low/undetectable C-peptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HLA associations in T1DM?

A

Accounts for 50% of genetic risk

HLA-DR2 confers protection
HLA-DR3 and HLA-DR4 confer risk

Strong linkage with HLA-DQA and HLA-DQB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk of T1DM with family history

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Latent autoimmune diabetes of adulthood (LADA) - features

A
  • Subtype of Type 1 diabetes
  • Slow progressive destruction of beta cells
  • May respond to oral agents initially
  • More likely to have autoimmune history
  • Less likely to have features of metabolic syndrome
  • Age of onset usually ≥30
  • Positive titre of at least 1 auto antibody
  • Starting insulin early may preserve beta cell function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Idiopathic T1DM (Type 1b) - features

A

○ Permanent insulinopenia (low/undetectable plasma C-peptide)
○ Ketoacidosis prone
○ No evidence of B cell autoimmunity
○ Strongly inherited - not HLA associated
○ Most are Africa/Asian ancestry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Autoimmune conditions associated with T1DM

A
  • AI thyroid disease*
  • Addison’s disease
  • Coeliac disease*
  • Vitiligo
  • AI hepatitis
  • Myasthenia gravis
  • AI gastritis* (increased risk of pernicious anaemia/B12 def)
  • Regular screening encouraged
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Autoimmune Polyendocrine Sndromes - type 2 - features

A
  • Characterised by presence of Addison’s disease with AI thyroid disease and/or T1DM
  • Female predominance
  • Most common of the Autoimmune Polyendocrine Syndromes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Typical starting dose of insulin

A

0.5 units/kg/day
50% as basal insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Human insulin vs. insulin analogues

A

Analogues associated with:
- Less hypoglycaemia
- Less weight gain
- Lower HbA1C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CSII vs. MDI (multiple daily injections)

A

Modest advantages for HbA1C lowering
Lower severe hypoglycaemia risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Insulin Carbohydrate Ratio (ICR)

A

How many grams of carbohydrate are covered/disposed of by 1 unit of insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Insulin Sensitivity Factor (ISF)

A

How much 1 unit of rapid acting insulin will generally lower BSL over 2-4 hours
- Expressed as mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SGLT2i in T1DM - outcomes of EASE trials?

A
  • HbA1C reduction
  • Body weight reduction
  • Lower total daily insulin requirement (up to 13%)
  • Lower SBP
  • Increased risk of ketoacidosis with 10mg & 25mg
  • No significant different in severe hypoglycaemic episodes
17
Q

Surgical options for T1DM?

A
  • Whole pancreas transplantation
    > Performed with curative intent
    > Usually performed with renal transplant
  • Islet cell transplantation
    > Indications: severe recurrent hypos/hypo unawareness

Both require lifelong immunosuppression to prevent graft rejection

18
Q

Risk factors for hypoglycaemic unawareness

A
  • Increasing age
  • Duration of disease
  • Aggressive glycaemic control
  • Frequent hypoglycaemic events
  • Autonomic neuropathy
  • Medications including beta blockers

Clarke Survey - assessment tool
- Score ≥4 = significantly impaired awareness of hypoglycaemia

19
Q

Level 1 vs. 2 vs. 3 hypoglycaemia

A

Level 1: typical symptoms associated with measured BSL of <4

Level 2: BSL <3, level at which neuroglycopenic symptoms expected to begin

Level 3: severe, requiring another person’s assistance

20
Q

What medications cause false positive aldosterone-renin ratios?

A

Beta blockers
Methyldopa, clonidine
NSAIDs

21
Q

What medications cause false negative aldosterone-renin ratios?

A

ACEi/ARBs
All diuretics
Dihydropyridine CCBs

22
Q

Results suggestive of Paget disease?

A

Isolated elevation of ALP
Normal calcium/phosphate/PTH
Xray - bone deformation/sclerotic/osteolytic lesions

23
Q

1st line management of Paget disease?

A

Bisphosphonates

24
Q

How to differentiate primary hyperparathyroidism vs. familial hypocalciuric hypercalcaemia?

A

Urinary calcium
Urinary Ca/Cr ratio

Both of these will be LOW in FHH
(<100mg/day and ratio <0.01)
In FHH: also have high serum Mg due to low urinary Mg

25
Q

What causes familial hypocalciuric hypercalcaemia?

A

Inactivating mutation in calcium sensing receptor in PTH and kidneys

26
Q

Polyglandular autoimmune syndrome type 2?

A

Primary adrenal insufficiency (Addison’s Disease)
T1DM
Autoimmune thyroid disease